The molecular interactions driving reactive centre loop (RCL) 1 insertion are of considerable interest in gaining a better understanding of the serpin inhibitory mechanism. Previous studies have suggested that interactions in the proximal hinge / breach region may be critical determinants of RCL insertion in serpins. In this study, conformational and functional changes in PAI-2 following incubation with a panel of synthetic RCL peptides indicated that the P14 residue is critical for RCL insertion, and hence inhibitory activity, in PAI-2. Only RCL peptides with a P14 threonine were able to induce the S→R transition and abolish inhibitory activity in PAI-2, indicating that RCL insertion into β-sheet A of PAI-2 is dependant upon this residue.
INTRODUCTION
The recent discovery of the crystallographic structure of the serpin-protease complex (1) confirms that the serpin inhibitory mechanism is dependent upon insertion of RCL into β-sheet A and the conformational changes associated with the stressed to relaxed (S→R) transition. By hyperstabilising the serpin structure and translocating the protease to the opposite end of the serpin molecule, RCL insertion effectively crushes the protease against the body of the serpin.
This in turn causes a striking loss of structure in the protease, making it susceptible to proteolytic degradation and preventing deacylation by distortion of the catalytic site (1) .
Relative rates of RCL insertion and deacylation determine partitioning between the substrate and inhibitory pathways of the reaction mechanism proposed by Wright and Scarsdale (2) . If RCL insertion and distortion of the protease active site can occur more rapidly than deacylation, the protease is kinetically trapped in a stable covalent complex and inhibited. However, if the rate of RCL insertion is decreased, or insertion is blocked completely, the substrate reaction predominates (2) . Hence, the molecular interactions driving RCL insertion are of considerable interest in order to gain a better understanding of the serpin inhibitory mechanism. We have previously shown that incubation with synthetic RCL analogues could induce the relaxed conformation of plasminogen activator inhibitor type-2 (PAI-2). However, RCL peptides lacking both the P13 and P14 residues (ie 12mer and shorter) were not able to induce relaxed
EXPERIMENTAL PROCEDURES
Materials: Recombinant human PAI-2 was a kind gift from Biotech Australia (Sydney). Human two-chain urokinase plasminogen activator (uPA) was purchased from Serono (Sydney). SDS-PAGE analysis showed that uPA in this preparation existed mainly in the 55kDa form.
SpectrolyseUK substrate was purchased from American Diagnostica (Sydney).
RCL Peptides:
A panel of PAI-2 RCL analogue peptides was synthesised incorporating deletions or mutations at the P13 and/or P14 sites (Table 1) . Peptide with a randomly scrambled sequence of the wild-type PAI-2 RCL was used as a control. Peptides were purified to >80% purity by RP-HPLC on a C 18 column and characterised by mass spectrometry (Auspep, Melbourne). All peptides were acetylated at the N-terminus. PAI-2/RCL complexes were prepared as previously described (3) .
Urea Denaturation & Fluorescence Spectroscopy:
Fluorescence spectroscopy was performed on a fluorescent plate reader (Molecular Dynamics) at an excitation wavelength of 280nm.
Fluorescence measurements were performed on 0.4µM PAI-2 (in 50mM Tris, 50mM NaCl, 8M urea) at an emission wavelength of 360nm. Data is presented as the fraction of protein (20) . Structural determination of the binary complex between PAI-2 (CD-loop deletion mutant) and 14mer RCL peptide (PDB# 1JRR) is described in the accompanying paper (21) . Alignment of the 225 serpin amino acid sequences available in the SwissProt and TrEMBL databases (releases 37 and 10 respectively) (22) was generated by ProDom99.2 (23) using PSI-BLAST with a profile built from the seed alignment of the PF00079 serpin entry of Pfam-A3.4. Sequences containing gaps or deletions at sites corresponding to either P14 or the top of s2B (Tyr 258 in PAI-2) were excluded from further analysis and pairwise frequencies of the remaining 198 serpin sequences were plotted.
RESULTS

P14 is Critical for Induction of Relaxed PAI-2 by RCL Peptide Insertion:
Intrinsic tryptophan fluorescence has previously been used to measure urea-induced denaturation of PAI-2. Incubation of PAI-2 with 14mer synthetic RCL peptide significantly increased resistance to urea denaturation, indicating induction of the relaxed conformation of PAI-2 following peptide insertion (3). Hence, measurement of conformational stability by intrinsic fluorescence spectroscopy provides a convenient method of detecting RCL insertion following incubation of PAI-2 with various mutated peptides. Figure 1 shows that PAI-2 incubated at 37 o C for 48h in the absence of any peptides (control) was completely denatured in the presence of 8M urea. However, PAI-2 incubated with wild-type 14mer peptide was resistant to denaturation by urea, indicating peptide insertion and subsequent transition to the more stable relaxed conformation. Incubation of PAI-2 with RCL peptide in which only the P13 residue had been mutated (E13Q, E13K) also induced resistance to urea denaturation, indicating peptide insertion and transition to the relaxed state. Note that a small fraction (~15%) of PAI-2 incubated with P13 mutant RCL peptides was denatured ( Figure 1 ). In contrast, incubation of PAI-2 with RCL peptides in which the P14 threonine was removed (13mer) or mutated to a valine (T14V) did not induce resistance to denaturation, indicating that these peptides were not able to insert and induce the relaxed conformation. Furthermore, peptides with mutations at both P14 and P13 (13K14V) did not induce resistance to urea denaturation, indicating that these peptides were not able to insert and induce the relaxed conformation ( Figure 1 ). Interestingly, PAI-2 incubated with scrambled peptide exhibited higher fluorescence in 8M urea than PAI-2 alone. As the scrambled peptide has no effect on PAI-2 inhibitory activity (see below) and PAI-2 is completely unfolded in 8M urea (3), this result may be an artifact of an unusual interaction between denatured PAI-2 and the scrambled peptide.
Regardless, it is clear that the scrambled peptide is unable to induce the relaxed conformation of PAI-2.
Effect of RCL Peptides on PAI-2 Inhibitory Activity:
We have previously shown (3) almost complete loss of uPA specific inhibitory activity of PAI- or mutation of the P14 residue effectively prevented synthetic RCL peptide insertion into PAI-2, whereas mutation of the P13 residue had little detectable affect.
The Structure of PAI-2/14mer Binary Complex Confirms RCL Insertion into β-sheet A:
The crystal structure of the binary complex formed between PAI-2 (C-D loop deletion mutant) and 14mer RCL peptide (ie. relaxed PAI-2) is shown in Figure 4C Tyr 258 (s2B) increases from 5.7 Å in stressed PAI-2 to 6.2 Å in relaxed PAI-2. A complete description of the structural differences between stressed and relaxed PAI-2 is provided in the accompanying paper (21) .
Structural Changes in the Proximal Hinge / Breach Region of Relaxed PAI-2:
Interactions between the 14mer peptide and adjacent residues in the breach region of relaxed PAI-2 are shown in Figure 4E . A similar illustration showing interactions around this region of relaxed LEI is presented in Figure 4F for comparison. The most prominent structural feature in this region of relaxed PAI-2 (and LEI) is the extensive rearrangement of hydrogen bonding upon insertion of the RCL. The three water molecules bound to this region in stressed PAI-2 ( Figure 4A ,B) are excluded and typical anti-parallel interstrand hydrogen-bonding is observed between all residues of the RCL (s4A) and adjacent residues in s3A and s5A, confirming that the peptide occupies the position that the endogenous RCL of PAI-2 would be expected to occupy following cleavage of the P1-P1' bond. complex involving residues immediately N-terminal to P14 (P15-P17) are difficult to interpret.
Normally this region would be expected to form the turn between strands 4 and 5 of β-sheet A (refer to the structure of relaxed LEI, Figure 4F ) but the insertion of a synthetic RCL analogue in place of the endogenous RCL prevents this from occurring. Hence, bonding in this region of the PAI-2/14mer complex is probably not entirely indicative of the situation in relaxed PAI-2 formed by target protease mediated cleavage of the P1-P1' bond. In addition to backbone hydrogen bonds with Gly 206 , the sidechain hydroxyl of P14 threonine in the RCL peptide forms a hydrogen bond with the sidechain hydroxyl of Tyr 258 on strand 2 of β-sheet B ( Figure   4E ). This interaction is also present in the structure of relaxed LEI, where the sidechain of Thr 345 is hydrogen bonded with sidechain of Tyr 244 ( Figure 4F ).
Comparison of Interactions Involving P14 and RCL Insertion in the Serpin Family:
Alignment of all serpin sequences available in the SwissProt and TrEMBL databases showed that the pairing of a threonine at P14 and tyrosine at the residue on s2B corresponding to Tyr 258 of PAI-2 is very highly conserved, occurring in ~69% of the 198 serpins analysed ( Figure 5 ).
However when only inhibitory serpins are considered, this frequency rises to 82%. The next most conserved pairing at this site (occurring in ~5% of the 198 sequences analysed) is a serine at P14 and tyrosine on s2B. Other pairings that occur less frequently (<3%) include arginine / phenylalanine (ovalbumin), alanine / leucine (PEDF), glycine / phenylalanine (maspin), asparagine / leucine (47kDa HSP), and glutamate / leucine (angiotensinogen) ( Figure 5 ). The residue on s3A (Gly 206 in PAI-2) that forms backbone hydrogen bonds with P14 is also highly conserved across the serpin family, with a glycine occuring in ~74.6% of the serpins analysed.
Alanine is the next most conserved residue at this site, occurring in ~20.2% of the sequences analysed. Interestingly, 47kDa heat shock protein and collagen binding protein, which are both non-inhibitory, have a proline residue at this site. Removal or replacement of the P14 residue may prevent synthetic RCL peptides from inserting into PAI-2 at all. Hence, only peptides with a threonine at P14 are able to insert into β-sheet A and block subsequent insertion of the endogenous RCL of PAI-2 upon interaction with uPA, converting PAI-2 into a substrate. Alternatively, RCL peptides in which the P14 residue was removed or mutated may still interact weakly with PAI-2, possibly only via partial insertion into β-sheet A. Upon interaction with uPA, the endogenous PAI-2 RCL may displace the weakly bound synthetic peptide and allow complete RCL insertion, formation of a stable uPA:PAI-2 complex and inhibition of the protease. The absence of any detectable changes in conformation of PAI-2 following incubation with mutated RCL peptides supports the former mechanism (ie.
complete lack of insertion). However, the later mechanism cannot be discounted as any conformational changes induced by partial insertion of mutated peptides may not be detectable by the methods used.
Definitive evidence for either mechanism would be provided by direct observation of a PAI-2/RCL peptide complex. Investigation of PAI-2/RCL complexes was attempted by electrospray mass spectrometry but this technique did not prove suitable as no evidence of any higher molecular weight species representing PAI-2/RCL complexes were detected. It is likely that any PAI-2/RCL complexes present were dissociated by the ionisation conditions required to achieve sufficient signal strength. Similarly, detection of RCL binding to PAI-2 using surface plasmon resonance analysis (BIAcore) was unsuccessful. Of most interest is the formation of a hydrogen bond in relaxed PAI-2 between the sidechain hydroxyl of P14 threonine and the sidechain hydroxyl of Tyr 258 on s2B ( Figure 4E ). Again, a similar arrangement is observed in relaxed LEI, with the sidechain of P14 (Thr 345 ) hydrogen bonded with the sidechain of Tyr 244 on s2B ( Figure 4F ). This is significant in light of experimental data indicating that replacement of the P14 threonine residue with a valine (T14V peptide) prevented RCL insertion (Figures 1-3) . In contrast to threonine, the sidechain of valine does not contain a donor/acceptor hydroxyl and hence cannot form a hydrogen bond with the aromatic hydroxyl of Tyr 258 . Whilst the Thr→Val replacement may alter sidechain mediated hydrogen bonding, it would not be expected to significantly affect backbone hydrogen bonding. Hence, bonding interactions between the sidechains of P14 and the adjacent tyrosine residue on s2B appear to be the main determinant of RCL insertion in PAI-2 and LEI.
Another possibly significant interaction in the structure of relaxed PAI-2 is the close proximity of the sidechains of P13 glutamate in the RCL peptide and Lys 205 on s3A, indicating a possible electrostatic interaction between these two residues. This interaction is also apparent in the structure of relaxed LEI, where the sidechain of P13 (Glu 346 ) is in close proximity to the sidechain of Lys 191 . Furthermore, analysis of interstrand bonding in β-sheet A across the serpin family indicated that P13 was a critical determinant of RCL insertion (12) . However, replacement of the P13 glutamate in the RCL peptide with either an uncharged glutamine (E13Q) or oppositely charged lysine (E13K) had only a small effect on the ability of these peptides to insert into PAI-2 ( Figures 1-3 ) suggesting that this interaction is not critical for RCL insertion in PAI-2.
A recent phylogenetic analysis of the serpin family (24) identified both the P14 residue and underlying tyrosine on s2B as highly conserved individually but did not examine the cooccurrence of these residues in various serpins. We have shown that the pairing of threonine at P14 with an adjacent tyrosine on s2B in the breach region is highly conserved in serpins, occuring in ~69% of all known serpins ( Figure 5 ). However, when only inhibitory serpins are considered, the frequency of this pairing is ~82%, hence it is likely to represent an important structural basis for RCL insertion and inhibitory activity. The next most conserved pairing at this site is a serine at P14 with a tyrosine on s2B (occurring in ~5% of known serpins; Figure   5 ). From a structural perspective, there is little difference in these pairings, as both threonine and serine have sidechain hydroxyl groups that can act as hydrogen donor/acceptors in formation of a hydrogen bond with the aromatic hydroxyl of tyrosine. Hence the overall conservation of this interaction in inhibitory serpins is ~87%.
It should be noted however, that this interaction is clearly not the sole determinant of RCL insertion and serpin inhibitory activity. The presence of the Thr/Tyr pairing in some non-inhibitory serpins indicates that structural deficiencies in other aspects of the serpin mechanism (eg. initial folding of the stressed form to provide the necessary energy for the S→R transition, or stabilisation of the RCL inserted/relaxed conformation) may be responsible for the lack of inhibitory activity in these molecules. Various alternative pairings occur at this site (albeit with much lower frequencies), however the majority of these appear in non-inhibitory serpins such as ovalbumin (Arg/Phe), PEDF (Ala/Leu), 47kDa HSP (Asn/Leu) and angiotensinogen (Glu/Leu). Interestingly, the P14/s2B interaction does not appear to be present in a few inhibitory serpins (eg. α 2 -antiplasmin, C1 inhibitor, factor XIIa inhibitor, antithrombin III),
suggesting that RCL insertion in these molecules may be facilitated by alternative mechanisms.
Different bonding patterns around the proximal hinge / breach region (including P14) in these serpins may be involved in separation of s3A and 5A and/or anchoring of the top of the RCL during insertion. However as no crystal structures are available for the relaxed conformations of these molecules, it is not possible to analyse the precise nature of these interactions.
Along with P13, Harrop et al. (12) also identified P8 as an important determinant of RCL insertion and inhibitory activity in serpins. Therefore, further investigation of the mechanism of RCL insertion in PAI-2 could involve performing similar experiments to those described above using synthetic RCL peptides in which the P8 amino acid is replaced. Further examination of the importance of the interaction between P14 and adjacent residues in β-sheets A and B for serpin inhibitory function may be facilitated through the generation of site-directed mutants of PAI-2. For example, mutation of Thr 367 (P14) and/or Tyr 258 (on s2B) would allow more direct comparisons of inhibitory activity and conformational stability between wild-type and mutant PAI-2 than is feasible using the synthetic RCL peptides described here. This approach was recently used to demonstrate the importance of P14 in determining the rate of RCL insertion (and hence partitioning between the inhibitory and substrate pathways) in PAI-1 (27) .
In summary, experimental evidence presented in this study indicates that the P14 residue is an important determinant of RCL insertion in PAI-2. Surprisingly, P13 does not appear to play a critical role in this process in PAI-2. Previous studies have identified constraints on the size and charge of residues in the proximal hinge region (particularly P14) of various serpins imposed by the tightly packed, hydrophobic nature of the protein core underlying β-sheet A (4-11).
Interactions around the proximal hinge / breach region (particularly those involving P14) most likely influence inhibitory activity by determining the rate of RCL insertion into β-sheet A, and hence partitioning between the inhibitory and substrate pathways (2) . Structural analysis of the breach regions in both relaxed PAI-2 and LEI indicate that a hydrogen bond between the sidechain hydroxyl of the P14 threonine and the aromatic hydroxyl on the sidechain of an adjacent tyrosine residue on s2B may be the main determinant of RCL insertion in these molecules. Furthermore, this interaction appears highly conserved in inhibitory serpins. 
